The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry

INTRODUCTION: The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic treatment outcome in real-world cohorts of Czech EMPIRE registry. PATIENTS/METHODS: Data of 611 Czech IPF subjects, 430 (70%) treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Štefániková, Marianna, Doubková, Martina, Ovesná, Petra, Šterclová, Martina, Lacina, Ladislav, Žurková, Monika, Plačková, Martina, Bartoš, Vladimír, Janíčková, Ivana, Bittenglová, Radka, Anton, Jan, Sýkorová, Ľubica, Lošťáková, Vladimíra, Musilová, Pavlína, Šuldová, Hana, Mokošová, Radka, Didyk, Jurij, Šišáková, Lenka, Lisá, Pavlína, Lněnička, Jaroslav, Dařičková, Hana, Doležel, Daniel, Pšikalová, Jana, Tyl, Richard, Králová, Renata, Vašáková, Martina Koziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155319/
https://www.ncbi.nlm.nih.gov/pubmed/37138274
http://dx.doi.org/10.1186/s12890-023-02450-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155319/
https://www.ncbi.nlm.nih.gov/pubmed/37138274
http://dx.doi.org/10.1186/s12890-023-02450-3

Ejemplares similares